Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Neurochemistry

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1471-4159.1997.69041629.XPMID 9326292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATP as a marker of excitotoxin-induced nerve cell death in vivo

  2005cited by this paper
• Mitochondrial defect in Huntington's disease caudate nucleus

  1996cited by this paper
• Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure

  1996cited by this paper
• A Reevaluation of the Role of Mitochondria in Neuronal Ca2+ Homeostasis

  1996cited by this paper
• Exogenous Glutamate Concentration Regulates the Metabolic Fate of Glutamate in Astrocytes

  1996cited by this paper
• Bioenergetics and glutamate excitotoxicity.

  1996cited by this paper
• Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation.

  1996cited by this paper
• Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity

  1996cited by this paper
• Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells

  1996cited by this paper
• Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain.

  1996cited by this paper
• Mitochondria and Na+/Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons

  1995cited by this paper
• Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate

  1995cited by this paper
• Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited.

  1995cited by this paper
• Involvement of Free Radicals in Excitotoxicity In Vivo

  1995cited by this paper
• Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

  1994cited by this paper
• Localization of neuronal and glial glutamate transporters.

  1994cited by this paper
• Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

  1994cited by this paper
• Ions and energy in mammalian brain.

  1994cited by this paper
• Calcium and excitotoxic neuronal injury.

  1994cited by this paper
• Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration

  1994cited by this paper
• Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.

  1994cited by this paper
• Nonvesicular release of neurotransmitter.

  1993cited by this paper
• NMDA-dependent superoxide production and neurotoxicity

  1993cited by this paper
• Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome.

  1993cited by this paper
• Disorders of Movement in Leigh Syndrome

  1993cited by this paper
• Cyclosporine A protects mitochondria in an in vitro model of hypoxia/reperfusion injury

  1993cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

  1993cited by this paper
• Regulation of gamma-aminobutyric acid synthesis in the brain.

  1993cited by this paper
• Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease

  1993cited by this paper
• Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat Striatum

  1993cited by this paper
• Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy.

  1993cited by this paper
• Metabolism of [U‐13C]Glutamate in Astrocytes Studied by 13C NMR Spectroscopy: Incorporation of More Label into Lactate than into Glutamine Demonstrates the Importance of the Tricarboxylic Acid Cycle

  1993cited by this paper
• Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.

  1993cited by this paper
• Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.

  1993cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats.

  1992cited by this paper
• Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.

  1992cited by this paper
• Glucose Metabolism Assessed with 2‐Deoxyglucose and the Effect of Glutamate in Subdivisions of Rat Hippocampal Slices

  1992cited by this paper
• Cortical glucose metabolism in Huntington's disease

  1992cited by this paper
• Role of poly(ADP-ribose) formation in DNA repair

  1992cited by this paper
• Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum.

  1991cited by this paper
• NADH Fluorescence and Regional Energy Metabolites during Focal Ischemia and Reperfusion of Rat Brain

  1991cited by this paper
• Hereditary spastic dystonia: a new mitochondrial encephalopathy? Putaminal necrosis as a diagnostic sign.

  1991cited by this paper
• Effect of Peroxide, Sodium, and Calcium on Brain Mitochondrial Respiration In Vitro: Potential Role in Cerebral Ischemia and Reperfusion

  1990cited by this paper
• Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes

  1990cited by this paper
• Mechanisms by which mitochondria transport calcium.

  1990cited by this paper
• Evidence for a defect in NADH

  1990cited by this paper
• Bioenergetic response of pancreatic islets to stimulation by fuel molecules.

  1989cited by this paper
• ATP and Brain Function

  1989cited by this paper
• Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

  1988cited by this paper
• Calcium in the mitochondria following brief ischemia of gerbil brain.

  1987cited by this paper
• The neurotransmitter amino acid transport systems. A fresh outlook on an old problem.

  1987cited by this paper
• Altered Mitochondrial Respiration in Selectively Vulnerable Brain Subregions Following Transient Forebrain Ischemia in the Rat

  1987cited by this paper
• Positron emission tomography in the early diagnosis of Huntington's disease

  1986cited by this paper
• PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline

  1986cited by this paper
• Expression of Classical Mitochondrial Respiratory Responses in Homogenates of Rat Forebrain

  1986cited by this paper
• Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

  1986cited by this paper
• Quantitative requirement for ATP for active transport in isolated renal cells.

  1986cited by this paper
• Leber's disease and dystonia

  1986cited by this paper
• The separation of o-phthalaldehyde derivatives of amino acids by reversed-phase chromatography on octylsilica columns.

  1986cited by this paper
• Selective sparing of a class of striatal neurons in Huntington's disease.

  1985cited by this paper
• Changes in Brain Energy Metabolism and Protein Synthesis Following Transient Bilateral Ischemia in the Gerbil

  1985cited by this paper
• Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain

  1985cited by this paper
• Active ion transport in the renal proximal tubule. III. The ATP dependence of the Na pump

  1984cited by this paper
• Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

  1984cited by this paper
• Rb+ influx in response to changes in energy generation: Effect of the regulation of the ATP content of HELa cells

  1984cited by this paper
• Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

  1983cited by this paper
• Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L-allylglycine.

  1983cited by this paper
• Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan

  1982cited by this paper
• Mitochondrial calcium transport.

  1982cited by this paper
• Effects of Kainic Acid on High‐Energy Metabolites in the Mouse Striatum

  1982cited by this paper
• Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks.

  1980cited by this paper
• Kainic acid lesion of mouse striatum: effects on energy metabolites.

  1980cited by this paper
• Hydroperoxide-induced loss of pyridine nucleotides and release of calcium from rat liver mitochondria.

  1980cited by this paper
• Defective poly(adenosine diphosphoribose) synthesis in xeroderma pigmentosum.

  1980cited by this paper
• The metabolic fate of 13N-labeled ammonia in rat brain.

  1979cited by this paper
• EVALUATION OF IN SITU FREEZING OF CAT BRAIN BY NADH FLUORESCENCE

  1978cited by this paper
• EFFECTS OF KAINIC ACID ON ION DISTRIBUTION AND ATP LEVELS OF STRIATAL SLICES INCUBATED IN VITRO

  1978cited by this paper
• A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea.

  1977cited by this paper
• OPTIMAL FREEZING CONDITIONS FOR CEREBRAL METABOLITES IN RATS

  1973cited by this paper
• The respiratory chain and oxidative phosphorylation.

  1956cited by this paper

• NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside

  2025cites this paper
• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Single nuclei RNA-seq reveals a medium spiny neuron glutamate excitotoxicity signature prior to the onset of neuronal death in an ovine Huntington’s disease model

  2024cites this paper
• Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications

  2024cites this paper
• Rodent Models of Huntington’s Disease: An Overview

  2023cites this paper
• Mitotherapy restores hippocampal mitochondrial function and cognitive impairment in aged male rats subjected to chronic mild stress

  2023cites this paper
• Evidence for glutamate excitotoxicity that occurs before the onset of striatal cell loss and motor symptoms in an ovine Huntington’s Disease model

  2023cites this paper
• From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research

  2023cites this paper
• Kynurenine Metabolism and Alzheimer’s Disease: The Potential Targets and Approaches

  2022cites this paper
• Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats

  2022cites this paper
• Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.

  2022cites this paper
• Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.

  2021cites this paper
• Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity

  2021cites this paper
• Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players

  2021cites this paper
• Kynurenines and Neurofilament Light Chain in Multiple Sclerosis

  2021cites this paper
• Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives

  2020cites this paper
• On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease

  2020cites this paper
• Effects of sulforaphane on brain mitochondria: mechanistic view and future directions

  2020cites this paper
• Neuropathology of Kynurenine Pathway of Tryptophan Metabolism

  2020cites this paper
• Diffusion Tensor Imaging in Preclinical and Human Studies of Huntington's Disease: What Have we Learned so Far?

  2019cites this paper
• Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices

  2018cites this paper
• Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders

  2018cites this paper
• Effect of wedelolactone and gallic acid on quinolinic acid‐induced neurotoxicity and impaired motor function: significance to sporadic amyotrophic lateral sclerosis

  2018cites this paper
• Quinolinic Acid-Induced Huntington Disease-Like Symptoms Mitigated by Potent Free Radical Scavenger Edaravone—a Pilot Study on Neurobehavioral, Biochemical, and Histological Approach in Male Wistar Rats

  2018cites this paper
• Deciphering the interplay between peripheral and central cytokine- and kynurenine pathways : importance for the pathophysiology of schizophrenia

  2018cites this paper
• Potassium channel dysfunction in neurons and astrocytes in Huntington's disease

  2018cites this paper
• Apocynin protects against neurological damage induced by quinolinic acid by an increase in glutathione synthesis and Nrf2 levels.

  2017cites this paper
• Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.

  2017cites this paper
• Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

  2017cites this paper
• Cytoskeleton as a Target of Quinolinic Acid Neurotoxicity: Insight from Animal Models

  2017cites this paper
• Role of Kynurenine Pathway in Glioblastoma

  2017cites this paper
• Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina

  2017cites this paper
• Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria

  2016cites this paper
• The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.

  2016cites this paper
• Stereotactic Surgery in Rats

  2016cites this paper
• Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.

  2016cites this paper
• Quinolinic acid neurotoxicity: Differential roles of astrocytes and microglia via FGF-2-mediated signaling in redox-linked cytoskeletal changes.

  2016cites this paper
• Functional and Localization Studies of Human Kynurenine 3-Monooxygenase

  2016cites this paper
• Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I

  2016cites this paper
• Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice

  2016cites this paper
• Toxin-Induced Experimental Models of Learning and Memory Impairment

  2016cites this paper
• Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

  2015cites this paper
• Sulforaphane reduces the alterations induced by quinolinic acid: modulation of glutathione levels.

  2014cites this paper
• Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets

  2013cites this paper
• The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease

  2013cites this paper
• Characterization of mechanisms underlying neuronal survival and plasticity in Huntington's disease

  2013influential citation
• A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.

  2012cites this paper
• The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications

  2012cites this paper
• Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration

  2012cites this paper
• The Kynurenine Pathway

  2012cites this paper
• Quinolinic acid, the inescapable neurotoxin

  2012cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS NATURAIS E EXATAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS: BIOQUÍMICA TOXICOLÓGICA

  2011cites this paper
• The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease

  2011cites this paper
• Huntington’s disease and mitochondrial alterations: emphasis on experimental models

  2010cites this paper
• Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition.

  2010influential citation
• Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.

  2010cites this paper
• endotóxico induzido por LPS e hipertriptofanemia

  2010cites this paper
• Recent findings in kynurenine research in the field of experimental epilepsy and stroke models : Electrophysiological, behavioural and histological studies

  2009cites this paper
• Involvement of quinolinic acid in aids dementia complex

  2009cites this paper
• Efeitos da espermina sobre parâmetros motores, cognitivos e neuromorfológicos em um modelo experimental da doença de huntington

  2008cites this paper
• L-kynurenine: Metabolism and mechanism of neuroprotection

  2008cites this paper
• Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats

  2008cites this paper
• In vitro effect of quinolinic acid on energy metabolism in brain of young rats.

  2007cites this paper
• Integrative hypothesis for Huntington's disease: a brief review of experimental evidence.

  2007cites this paper
• Animal models of Huntington's disease.

  2007cites this paper
• Kynurenines in neurological disorders

  2007cites this paper
• Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.

  2006cites this paper
• Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis

  2006cites this paper
• Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats

  2006cites this paper
• Efeito da administração intraestriatal aguda de ácido quinolínico sobre metabolismo energético em ratos jovens

  2006cites this paper
• Efeito in vitro de quinureninas sobre vários parâmetros de estresse oxidativo em córtex cerebral de ratos jovens

  2006cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BÁSICAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS

  2006cites this paper
• Neuroprotective effects of kynurenine and related compounds. Electrophysiological and behavioral studies

  2006cites this paper
• An investigation into the neuroprotective properties of acyclovir

  2006cites this paper
• Efeito in vitro de quinureninas sobre parâmetros bioquímicos do metabolismo enrgético em cérebro de ratos jovens

  2005cites this paper
• The Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Homeostasis following Striatal Quinolinic Acid Injections

  2005cites this paper
• Role of kynurenines in the central and peripheral nervous systems.

  2005cites this paper
• Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation.

  2005cites this paper
• Modulação do sistema glutamatérgico : estudo dos efeitos do ácido quinolínico e dos derivados da guanina

  2005cites this paper
• 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships.

  2004cites this paper
• Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease.

  2003cites this paper
• Therapeutics in Huntington’s Disease

  2002cites this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cites this paper
• Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease

  2002cites this paper
• Nitric oxide synthase inhibition and glutamate binding in quinolinate-lesioned rat hippocampus.

  2002cites this paper
• The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines

  2001cites this paper
• Endogenous neurotoxins from tryptophan.

  2001cites this paper
• Metabolic changes in quinolinic acid‐lesioned rat striatum detected non‐invasively by in vivo 1H NMR spectroscopy

  2001influential citation
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Quinolinic acid lesion induces changes in rat striatal glutathione metabolism.

  2000cites this paper
• Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.

  2000cites this paper
• Neuroprotective effects of creatine administration against NMDA and malonate toxicity.

  2000cites this paper
• Energetics in the pathogenesis of neurodegenerative diseases.

  2000cites this paper
• Neural Grafting for Parkinson’s and Huntington’s Disease

  2000cites this paper
• Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum

  1999cites this paper
• Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.

  1999cites this paper
• Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo.

  1998cites this paper